Biotech Values

[DewDiligence]

what if MNTA gets its approval, and say a few weeks or a few months or even a year or more later a competitor gets their approval, will MNTA's royalty rates drop back into the low to mid-teens, or will it stay in the mid to high 40s?

The economic terms of the NVS-MNTA Lovenox partnership change prospectively if there is a new entrant in the marketplace. Note that in the single-generic case, MNTA’s economic interest is not a royalty on sales (as per the language in your question), but rather a 40-50% profit split. Regards, Dew